(Q38942860)

https://doi.org/10.3892/or.2021.8125

7 September 2017

1 reference

29 December 2023

title

Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo (English)

1 reference

7 September 2017

1 reference

1 reference

Qi Zhang

1

1 reference

7 September 2017

Weiqun Yan

2

1 reference

7 September 2017

Yang Bai

3

1 reference

7 September 2017

Hao Xu

4

1 reference

7 September 2017

Changhao Fu

5

1 reference

7 September 2017

Wenwen Zheng

6

1 reference

7 September 2017

Yingqiao Zhu

7

1 reference

7 September 2017

Jie Ma

8

1 reference

7 September 2017

publication date

5 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

33

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

448-456

1 reference

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

7 September 2017

cites work

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.CCR.2010.09.005

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Clinical applications for microRNAs in cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

p53 represses c-Myc through induction of the tumor suppressor miR-145

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Molecular targets for the treatment of multiple myeloma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

G1 cell-cycle control and cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA signatures in human cancers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-145 targets YES and STAT1 in colon cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

New strategies in the treatment of multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Targeting microRNAs in cancer: rationale, strategies and challenges

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-cancer connection: the beginning of a new tale

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Causes and consequences of microRNA dysregulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

The potential clinical applications and prospects of microRNAs in lung cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Oncomirs - microRNAs with a role in cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNAs: target recognition and regulatory functions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Molecular pathogenesis of multiple myeloma: basic and clinical updates

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Promises and challenges of MicroRNA-based treatment of multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Oncomirs: the potential role of non-coding microRNAs in understanding cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Deregulated expression of miR-145 in manifold human cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2014.3591

Identifiers

DOI

10.3892/OR.2014.3591

1 reference

release_3pmgu2ranjezjphph72nngkl3i

7 September 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/3pmgu2ranjezjphph72nngkl3i

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference